Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Transl Psychiatry ; 3: e222, 2013 Jan 22.
Article in English | MEDLINE | ID: mdl-23340505

ABSTRACT

Epistatic gene-gene interactions could contribute to the heritability of complex multigenic disorders, but few examples have been reported. Here, we focus on the role of aberrant dopaminergic signaling, involving the dopamine transporter DAT, a cocaine target, and the dopamine D2 receptor, which physically interacts with DAT. Splicing polymorphism rs2283265 of DRD2, encoding D2 receptors, were shown to confer risk of cocaine overdose/death (odds ratio ∼3) in subjects and controls from the Miami Dade County Brain Bank.(1) Risk of cocaine-related death attributable to the minor allele of rs2283265 was significantly enhanced to OR=7.5 (P=0.0008) in homozygous carriers of the main 6-repeat allele of DAT rs3836790, a regulatory VNTR in intron8 lacking significant effect itself. In contrast, carriers of the minor 5-repeat DAT allele showed no significant risk (OR=1.1, P=0.84). DAT rs3836790 and DRD2 rs2283265 also interacted by modulating DAT protein activity in the ventral putamen of cocaine abusers. In high-linkage disequilibrium with the VNTR, DAT rs6347 in exon9 yielded similar results. Assessing the impact of DAT alone, a rare DAT haplotype formed by the minor alleles of rs3836790 and rs27072, a regulatory DAT variant in the 3'-UTR, occurred in nearly one-third of the cocaine abusers but was absent in African American controls, apparently conferring strong risk. These results demonstrate gene-gene-drug interaction affecting risk of fatal cocaine intoxication.


Subject(s)
Cocaine-Related Disorders/genetics , Cocaine/poisoning , Dopamine Plasma Membrane Transport Proteins/genetics , Dopamine Uptake Inhibitors/poisoning , Receptors, Dopamine D2/genetics , Adult , Case-Control Studies , Cocaine-Related Disorders/mortality , Drug Overdose , Epistasis, Genetic , Female , Gene-Environment Interaction , Genetic Predisposition to Disease , Haplotypes , Humans , Logistic Models , Male , Middle Aged , Minisatellite Repeats , Odds Ratio , Polymorphism, Genetic , Prefrontal Cortex/metabolism , Putamen/metabolism
2.
Clin Pharmacol Ther ; 89(3): 355-65, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21289622

ABSTRACT

The use of pharmacogenomic biomarkers can enhance treatment outcomes. Regulatory polymorphisms are promising biomarkers that have proven difficult to uncover. They come in two flavors: those that affect transcription (regulatory single-nucleotide polymorphisms (rSNPs)) and those that affect RNA functions such as splicing, turnover, and translation (termed structural RNA SNPs (srSNPs)). This review focuses on the role of srSNPs in drug metabolism, transport, and response. An understanding of the nature and diversity of srSNPs and rSNPs enables clinical scientists to evaluate genetic biomarkers.


Subject(s)
Pharmaceutical Preparations/metabolism , Pharmacogenetics , Polymorphism, Single Nucleotide , RNA/metabolism , Biomarkers/metabolism , Genetic Markers , Genetic Variation , Humans , Pharmaceutical Preparations/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...